Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

7
AVD / American Vanguard Corp. 8-K (Current Report)

2018-06-22 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

7
AVD / American Vanguard Corp. 8-K (Current Report)

2018-06-11 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

8
AVD / American Vanguard Corp. FORM 8-K (Current Report)

2018-05-10 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

12
American Vanguard (AVD) Q1 Earnings Beat, Sales Miss Estimates

2018-05-09 zacks
American Vanguard Corporation (AVD - Free Report) profits for first-quarter 2018 were around $4.7 million or 16 cents per share, up around 36.4% from roughly $3.5 million or 12 cents a year ago. Earnings per share beat the Zacks Consensus Estimate of 14 cents. Revenues surged 47.2% year over year to $104.1 million in the reported quarter. The figure however, missed the Zacks Consensus Estimate of $108 million.
HUN KRO STLD AVD

7
American Vanguard Corporation's (AVD) CEO Eric Wintemute on Q1 2018 Results - Earnings Call Transcript

2018-05-09 seekingalpha
Greetings and welcome to the American Vanguard Corporation First Quarter 2018 Conference Call and Webcast. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
AVD

9
AVD / American Vanguard Corp. 10-Q (Quarterly Report)

2018-05-08 sec.gov
avd-10q_20180331.htm UNITED STATES SE
AVD

38
New Strong Sell Stocks for April 30th

2018-04-30 zacks
Altisource Portfolio Solutions S.A. (ASPS - Free Report) is an integrated service provider for the real estate and mortgage industries. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 60 days.
BHF BCBP AVD BLDP

7
AVD / American Vanguard Corp. DEF 14A

2018-04-23 sec.gov
avd-def14a_20180606.htm SCHEDULE 14A INFORMATION
AVD

7
AVD / American Vanguard Corp. FORM 8-K (Current Report)

2018-04-06 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

33
New Strong Sell Stocks for April 3rd

2018-04-03 zacks
Actuant Corporation (ATU - Free Report) is a manufacturer and distributor of a variety of industrial products and systems. The Zacks Consensus Estimate for its current year earnings has been revised 3.7% downward over the last 30 days.
ATU DK PSTG NXT USAPF BWP UTX SMNPF USAS AVD CBL

23
New Strong Sell Stocks for March 28th

2018-03-28 zacks
American Vanguard Corporation (AVD - Free Report) is a manufacturer of specialty chemicals. The Zacks Consensus Estimate for its current year earnings has been revised 8.1% downward over the last 30 days.
EDR HBB TXN CLDT OHI AVD SGH

8
AVD / American Vanguard Corp. 8-K (Current Report)

2018-03-26 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

50
New Strong Sell Stocks for March 23rd

2018-03-23 zacks
Airgain, Inc. (AIRG - Free Report) is a developer of embedded antenna technologies. The Zacks Consensus Estimate for its current year earnings has been revised 17.7% downward over the last 30 days.
CECE BT.A AVY APU QTS.PRA AIRG BTGOF QTS AVD HAIR BT

7
AVD / American Vanguard Corp. 10-K (Annual Report)

2018-03-14 sec.gov
avd-10k_20171231.htm UNITED STATES
AVD

7
AVD / American Vanguard Corp. FORM 8-K (Current Report)

2018-03-14 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
AVD

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

6h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to AVD / American Vanguard Corp. on message board site Silicon Investor.

Avadel AVDL Aavdex Corporation
AVDO: Avado Brands, Inc. AVDL - Avondale Industries ( Ship Builder)
CUSIP: 030371108